# A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

> clinical trial · VERIFIED · 2026-08-28

Status: RECRUITING · Sponsor: Janssen Research & Development, LLC · Condition: Non-Muscle Invasive Bladder Neoplasms

- Company: Janssen Research & Development, LLC
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06319820

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.